Menopause: Biology and Pathobiology

Lobo, Rogerio A.; Kelsey, Jennifer; Marcus, Robert

In stock
Regular price 90.750 KD inc. VAT
License
Table of contents
  • Cover
  • Menopause: Biology and Pathobiologyiii
  • Copyright Pageiv
  • Contentsv
  • Contributorsxiii
  • Prefacexvii
  • Part I: Basic Biology1
  • Chapter 1. Molecular Pharmacology of Estrogen and Progesterone Receptors3
  • I. Introduction3
  • II. Estrogen and Progesterone Receptors3
  • III. Established Models of Estrogen and Progesterone Action4
  • IV. Estrogen and Progesterone Receptor Isoforms and Subtypes5
  • V. Regulation of Estrogen and Progesterone Receptor Function by Ligands6
  • VI. Estrogen and Progesterone Receptor Associated Proteins8
  • VII. An Updated Model of Estrogen and Progesterone Receptor Action9
  • References9
  • Chapter 2. Ovarian Anatomy and Physiology13
  • I. Introduction13
  • II. Statement of the Problem13
  • III. The Primordial Follicle14
  • IV. The Adult Ovary15
  • V. Ovary Reserve21
  • VI. Accelerated Loss in OR: Activin Hypothesis26
  • VII. New Data on the Effects of Activin28
  • VIII. Statement of Conclusion28
  • References28
  • Chapter 3. Regulation of the Hypothalamic–Pituitary–Gonadal Axis: Role of Gonadal Steroids and I33
  • I. Introduction33
  • II. Functional Organization of the Hypothalamic–Pituitary–Ovarian Axis34
  • III. Anatomical and Biochemical Correlates of Gonadal Steroid Hormone Action in the Central Nervous37
  • IV. Ovarian Steroid Action in the Central Nervous System„Control of Reproduction41
  • V. The Menopause: Consequences of Steroid Hormone Loss on the Central Nervous System46
  • References51
  • Chapter 4. Gonadotropins and Menopause: New Markers61
  • I. Introduction61
  • II. Gonadotropin Parameters of the Normal Menstrual Cycle62
  • III. Structures of Gonadotropins and Their Fragments63
  • IV. Assay of Gonadotropins65
  • V. Changes in Gonadotropin Patterns in Menopause68
  • VI. Gonadotropin Fragments as Urinary Analytes70
  • References73
  • Chapter 5. Genetic Programming in Ovarian Development and Oogenesis77
  • I. Ovarian Differentiation Requires Only One X (Constitutive)77
  • II. Polygenic and Stochastic Control over Oocyte Number78
  • III. Monosomy X78
  • IV. X Chromosomal Mosaicism: 45,X/46,XX and 45,X/47,XXX80
  • V. Pitfalls in Localizing Ovarian Maintenance Genes to Specific Regions of the X81
  • VI. Genes on the X Short Arm81
  • VII. Genes on the X Long Arm83
  • VIII. Nature of X Ovarian Maintenance Determinants84
  • IX. Autosomal Chromosomal Abnormalities85
  • X. Autosomal Genes (Mendelian)85
  • XI. To What Extent is Premature Ovarian Failure Genetic?91
  • References91
  • Chapter 6. Neuroendocrine Regulation of the Perimenopause Transition95
  • I. Definition of Perimenopause95
  • II. Ovarian Determinants of Reproductive Aging96
  • III. Dynamic Gonadotropin Secretion in Young Women98
  • IV. Gonadotropin Changes during Perimenopause100
  • V. The Neuroreproductive Axis in Postmenopause102
  • VI. Brain Aging and Reproductive Senescence106
  • VII. Future Studies106
  • References108
  • Chapter 7. Changes in Men as They Age: The Manopause111
  • I. Introduction111
  • II. Age-Related Changes in the Male Reproductive System112
  • III. Age-Related Changes in Other Hormonal Systems115
  • IV. Other Changes with Aging Related to Hormonal Factors118
  • V. Androgen Effects on Sexual and Reproductive Function119
  • VI. Nonerectile Sexual Dysfunctions119
  • VII. Erectile Dysfunction120
  • VIII. Manopause and Mental Health124
  • IX. Psychological State and Sexual Function127
  • X. Conclusions127
  • References128
  • Chapter 8. Premature Ovarian Failure135
  • I. Early Reports of Premature Ovarian Failure135
  • II. Clinical Features of Premature Ovarian Failure136
  • III. Prevalence of Premature Ovarian Failure137
  • IV. Etiology of Premature Ovarian Failure138
  • V. Evaluation of Patients with Hypergonadotropic Amenorrhea142
  • VI. Therapy142
  • References143
  • Chapter 9. Perimenopausal Changes in FSH, the Inhibins, and the Circulating Steroid Hormone Milieu147
  • I. Introduction and Definitions147
  • II. Current Concepts of Ovarian Physiology as a Function of Age148
  • III. Major Longitudinal Studies of Steroids in Relation to the Final Menstrual Period150
  • IV. Hormonal Studies during the Menopausal Transition150
  • V. Conclusions154
  • References154
  • Part II: Epidemiology157
  • Chapter 10. Epidemiology: Methodologic Challenges in the Study of Menopause159
  • I. Introduction159
  • II. Study Design159
  • III. Data Collection Methods163
  • IV. Measurement Issues164
  • V. Analytic Considerations167
  • VI. Conclusion171
  • References171
  • Chapter 11. SWAN: A Multicenter, Multiethnic, Community-Based Cohort Study of Women and the Menopaus175
  • I. Introduction175
  • II. Overview of the Study Design176
  • III. Data Collection177
  • IV. Sampling and Recruitment179
  • V. Strengths and Limitations of SWAN183
  • VI. Summary185
  • Appendix A. SWAN Investigators185
  • Appendix B. Specific Sampling and Recruiting Strategies by Sites with List-Based Primary Sampling Fr186
  • Appendix C. Specific Sampling and Recruiting Strategies by Sites with RDD-Based Primary Sampling Fra187
  • References188
  • Chapter 12. Demographics, Environmental Influences, and Ethnic and International Differences in the189
  • I. Introduction189
  • II. Demographic Characteristics191
  • III. Ethnic and International Differences193
  • IV. Environmental Influences193
  • V. Conclusions196
  • References197
  • Chapter 13. Distinguishing the Effects of Age from Those of Menopause203
  • I. Introduction203
  • II. Statement of the Problem204
  • III. Manifestations of Aging versus Menopause204
  • IV. Conclusions208
  • References208
  • Part III: Menopausal Systems Pathophysiology213
  • Chapter 14. Menopausal Hot Flashes215
  • I. Epidemiology of Hot Flashes215
  • II. Descriptive Physiology215
  • III. Objective Measurement of Hot Flashes218
  • IV. Endocrinology219
  • V. Thermoregulation and Hot Flashes221
  • VI. Circadian Rhythms222
  • VII. Sleep222
  • VIII. Treatment of Hot Flashes223
  • IX. Summary and Conclusions224
  • References225
  • Chapter 15. Cardiovascular Pathophysiology229
  • I. Introduction229
  • II. Sex-Specific Trends in Cardiovascular Risk with Age230
  • III. Epidemiologic Studies of Menopause and Cardiovascular Outcomes230
  • IV. Studies of Menopause and Cardiovascular Risk Factors234
  • V. Conclusions239
  • References239
  • Chapter 16. Insulin Resistance, Body Weight, Obesity, Body Composition, and the Menopausal Transitio245
  • I. Introduction245
  • II. Mechanisms for Sex Hormones, Body Composition/ Topology, and Insulin Regulation246
  • III. Ovarian Hormone Status and Body Composition/ Body Topology248
  • IV. Carbohydrate Metabolism and Change in Ovarian Hormone Status251
  • V. Linking Body Composition and Carbohydrate Metabolism with Hormone Status253
  • VI. Summary253
  • Appendix254
  • References257
  • Chapter 17. Influence of Estrogen on Collagen261
  • I. Introduction261
  • II. Structure of Collagen261
  • III. Age-Related Changes in Collagen262
  • IV. Skin263
  • V. Carotid Arteries266
  • VI. Urinogenital System267
  • VII. Concluding Remarks268
  • References268
  • Chapter 18. The Growth Hormone IGF-I Axis and Menopause271
  • I. Introduction271
  • II. Physiology of the GH/IGFs271
  • III. Diseases in Postmenopausal Life and Their Relationship to the GH/IGF-I Axis277
  • IV. Summary282
  • References282
  • Chapter 19. Bone and Calcium287
  • I. Biology of Ovarian Hormone Effects on the Skeleton287
  • II. Review of Bone Structure and Function288
  • III. Integration of Bone Cell Activity289
  • IV. Estrogen Effects on Epithelial Calcium Transport294
  • V. Estrogen and the Physiology of Calcium Homeostasis297
  • References303
  • Chapter 20. Menopause and the Skin309
  • I. Introduction309
  • II. Dryness309
  • III. Sweating310
  • IV. Atrophy310
  • V. Slowed Wound Healing311
  • VI. Topical Hormone Replacement Therapy312
  • VII. Psychological Effects of Menopausal Changes Related to Skin Appearance„Self-Image313
  • VIII. Summary313
  • References313
  • Chapter 21. Estrogen Therapy and the Brain315
  • I. Chapter Overview315
  • II. Estrogen and the Brain315
  • III. Estrogen Therapy and Cognitive Skills316
  • IV. Estrogen Therapy, Affective Disorders, And Mood317
  • V. Estrogen Therapy and Alzheimer's Disease317
  • VI. Estrogen Therapy and Stroke320
  • VII. Estrogen Therapy and Parkinson's Disease321
  • VIII. Concluding Perspective on Estrogen and the Brain321
  • References322
  • Chapter 22. The Gynourinary System327
  • I. Introduction327
  • II. Anatomy and Physiology328
  • III. Innervation329
  • IV. Mechanisms of Continence330
  • V. Treatment Modalities for Female Urinary Incontinence331
  • References336
  • Chapter 23. Is There a Relationship between Menopause and Mood?339
  • I. Introduction339
  • II. Theories of Menopause and Mood340
  • III. Methodological Issues340
  • IV Empirical Research: Menopause Status and Mood342
  • V. Empirical Research: Hormones and Mood347
  • VI. Conclusions348
  • References349
  • Chapter 24. Immunologic Aspects of Menopause353
  • I. Effects of Steroid Hormones on the Immune System353
  • II. Somatic Aging of the Immune System355
  • III. Effects of the Immune System and Its Decline on Other Events Associated with Menopause355
  • IV. Hormone Replacement Therapy„Effects on Autoimmunity and Immune Function356
  • V. Conclusions356
  • References356
  • Chapter 25. Cancers of the Female Reproductive System359
  • I. Introduction359
  • II. Breast Cancer360
  • III. Endometrial Cancer365
  • IV. Cancer of the Cervix370
  • V. Ovarian Cancer372
  • VI. Summary and Conclusions376
  • References376
  • Chapter 26. Menopausal Sexuality383
  • I. Introduction383
  • II. Menopausal Sexuality383
  • III. Role of Estrogen385
  • IV. Androgens and Postmenopausal Sexual Function387
  • V. Other Factors387
  • VI. Partner, Relationship, and Menopausal Sexuality389
  • VII. Interventions for Sexual Dysfunction390
  • References392
  • Part IV Intervention395
  • Chapter 27. Historical Perspectives397
  • I. Introduction397
  • II. Biological Considerations398
  • III. Psychologic Aspects402
  • IV. Sociocultural Perspectives402
  • References403
  • Chapter 28. Prevention Trials in Perimenopausal and Postmenopausal Women405
  • I. Introduction405
  • II. Hormone Replacement Therapy: Background406
  • III. The Postmenopausal Estrogen/ Progestin Trial406
  • IV. The Women's Health Initiative408
  • V. Heart Estrogen /Progestin Replacement Study411
  • VI. The Women's Health Study412
  • VII. The Breast Cancer Prevention Trial413
  • VIII. Recent Trials of Agents That Reduce Bone Loss and Fracture Incidence414
  • IX. Study of Tamoxifen and Raloxifene417
  • X. Conclusion417
  • References417
  • Chapter 29. Estrogens: Different Types and Properties421
  • I. Steroidal Estrogens421
  • II. Nonsteroidal Estrogens423
  • III. Potency of Estrogens427
  • References427
  • Chapter 30. Progestogens429
  • I. Introduction429
  • II. Rationale for Use of Progestogens429
  • III. Progestogen Biologic Aspects430
  • IV. Conclusions441
  • References441
  • Chapter 31. Androgens445
  • I. Introduction445
  • II. Androgen Physiology in the Reproductive Years446
  • III. Physiological and Nonphysiological Causes of Testosterone Deficiency in Women446
  • IV. Clinical Consequences of Androgen Insufficiency and Evidence for Benefits of Testosterone Replac447
  • V. Potential Risks of Testosterone Replacement in Women451
  • VI. Which Women Are Most Likely to Benefit from Testosterone Replacement?453
  • VII. How Should Testosterone Replacement Be Prescribed?454
  • VIII. Conclusions455
  • References456
  • Chapter 32. Alternative Therapies to Hormone Replacement Therapy459
  • I. Introduction459
  • II. Phytoestrogens460
  • III. Herbs469
  • IV. Selective Estrogen Receptor Modulator: Raloxifene474
  • V. Recommendations474
  • References476
  • Chapter 33. Calcium Nutriture: A Model System for Understanding Menopause–Nutrient Interactions481
  • I. Introduction481
  • II. Calcium482
  • III. Vitamin D491
  • References492
  • Chapter 34. Exercise495
  • I. Introduction495
  • II. Physical Activity and Age at Menopause495
  • III. Physical Activity and Vasomotor Symptoms496
  • IV. Physical Activity and Psychological and Somatic Symptoms497
  • V. Physical Activity and Change in Disease Risk Factor Status499
  • VI. Conclusions504
  • References504
  • Chapter 35. Estrogens and Osteoporosis509
  • I. Magnitude of the Disease509
  • II. Definition of Osteoporosis509
  • III. Bone Mineral Density510
  • IV. Bone Remodeling512
  • V. Treatment of Postmenopausal Osteoporosis514
  • References527
  • Chapter 36. Osteoarthritis and Menopause535
  • I. Introduction535
  • II. Pathogenesis: Potential Mechanisms for the Role of Estrogen and Osteoarthritis536
  • III. Observations Related to Clinical or Epidemiological Studies537
  • IV. Summary540
  • References540
  • Chapter 37. The Epidemiology of Cardiovascular Disease and Postmenopausal Hormone Therapy543
  • I. Introduction543
  • II. Primary Prevention of Cardiovascular Disease and Stroke544
  • III. Secondary Prevention of Cardiovascular Disease547
  • IV. Association of Hormones with Lower Risk of CHD: Cause and Effect or Selection?548
  • V. Summary550
  • References550
  • Chapter 38. Interventions for the Control of Symptoms553
  • I. Introduction553
  • II. Disturbances in Menstrual Patterns554
  • III. Symptoms Due to a Decrease in Estrogen555
  • IV. Symptoms Associated with Progestin Treatment559
  • V. Conclusion559
  • References560
  • Chapter 39. Effects of Steroids on Mood/Depression563
  • I. Introduction563
  • II. Mood Disorders across the Female Life Cycle565
  • III. Brain Neurotransmitters and Mood569
  • IV. Catecholestrogens: The Estrogen-Mediated System in the Brain571
  • V. The Hypothalamic–Pituitary Axes571
  • VI. Steroid Hormones: Mechanism and Modulation of Neuronal Effects572
  • VII. Conclusion579
  • References580
  • Chapter 40. Hormone Replacement Therapy and Breast Cancer583
  • I. Background583
  • II. Steroid Hormones and Breast Cancer583
  • III. Patterns of HRT Use584
  • IV. Epidemiological Studies of the HRT/Breast Cancer Association585
  • V. Discussion588
  • References589
  • Chapter 41. HRT and Risk of Endometrial Cancer591
  • I. Endometrial Cancer591
  • II. Estrogen and Progestin Therapy599
  • III. Endometrial Surveillance602
  • IV. Physiology of Endometrial Shedding603
  • V. Summary603
  • References604
  • Chapter 42. Risk of Pulmonary Embolism/Venous Thrombosis607
  • I. Clinical Entities607
  • II. Diagnosis and Treatment608
  • III. Pathophysiology608
  • IV Incidence and Prognosis609
  • V. Clinical Recommendations613
  • References614
  • Chapter 43. Combined Estrogen/ Androgen Replacement Therapy: Benefits and Risks617
  • I. Introduction617
  • II. Historical Background617
  • III. Benefits of E/A Replacement Therapy618
  • IV. Risks of E/A Replacement Therapy620
  • V. Future Directions622
  • References623
  • Chapter 44. DHEA: Biology and Use in Therapeutic Intervention625
  • I. Introduction625
  • II. Androgens: Origin and Control625
  • III. DHEA, DHEAS, and Androgen Metabolites: Increase during Childhood and Decline with Age630
  • IV. DHEA Replacement632
  • V. Conclusions636
  • References637
  • Chapter 45. Menopause Issues for Older Women639
  • I. Introduction639
  • II. Selected Syndromes and Late Menopausal Women640
  • III. Therapeutic Considerations in Late Menopausal Women643
  • IV Conclusions645
  • References646
  • Chapter 46. Decision Analysis Applied to Postmenopausal Hormone Replacement Therapy649
  • I. Introduction649
  • II. Decision Analysis649
  • III. Review of Studies650
  • IV. Treatment Regimens651
  • V. Treatment Risks and Benefits651
  • VI. Estimated Changes in Life Expectancy652
  • VII. Limitations653
  • VIII. Summary653
  • References654
  • Index657
  • Color Plate SectionPlate 1
Book details
  • Vendor Elsevier S & T
  • SKU 9780124537903
  • ISBN-13 9780080536200
  • Author Lobo, Rogerio A.; Kelsey, Jennifer; Marcus, Robert
  • Category Medical
  • Subject Gynecology & Obstetrics

Do you have questions about this book?

Ask an expert!

Menopause: Biology and Pathobiology is a comprehensive volume covering all aspects of the biology, anatomy, physiology, pathobiology, and pharmacology of menopause, as well as its diagnosis and management.
The book is divided into four sections: Basic Biology, Epidemiology, Menopausal Systems Pathophysiology, and Intervention. Basic Biology covers such fundamentals as ovarian anatomy and physiology, mechanisms of steroid hormone action, chronobiological effects, and premature menopause. Epidemiology includes, among others, chapters on methodology challenges in the study of menopause, how to distinguish the effects of age from those of menopause, and a discussion of the key differences in demographics, environmental factors, and ethnicity in the menopause experience. The Pathophysiology section contains chapters on menopause and its various effects on the body, including sexuality, skin, brain, the cardiovascular system, cancers, and mood. The final section includes detailed chapters on intervention and management techniques, with topics including alternative therapies to hormone replacement, exercise, and estrogens and osteoporosis.

* Well-referenced to allow easy look up of anything related to menopause
* Presents the latest thinking on basic science and clinical topics
* Exposes what the current gaps in our knowledge are
* Presents current expert opinions